Skip to Content

Resources

Article

May 27, 2026

Early Decisiona, Faster Launch: Optimizing combination Product Commercialization

More

Article

May 21, 2026

Advancing Sterile Liquid Development: Enabling Integrated Solutions for Small Molecules and Biologics

More

Article

April 28, 2026

Optimizing Clinical Trials for the Era of Self-Injectable Combination Products

More

Article

April 24, 2026

Annex 1, Sterility Assurance, and the Rising Bar for PUPSIT

More

Article

April 22, 2026

An integrated path: How CDMOs are reshaping complex drug development

More

Article

April 08, 2026

Extreme Language: “Ultra-High Potency”

More

All articles

Webinar

December 08, 2025

From Clinical to Commercial: Introducing Devices Earlier to Streamline the Drug-Device Combination Journey. Achieving scalability, flexibility, and integration from Phase I to Commercial Launch

More

expertXchange

December 01, 2025

Common Challenges in Early Clinical Trial Planning. Early clinical trial planning sets the foundation for success when navigating packaging, labeling, and logistics for your first-in-human study.

More

Webinar

August 19, 2025

Navigating Global Trade Complexities in Pharma: Tariffs, VAT, and Free Trade Zones Explained. understanding how to manage trade compliance and optimize international supply chains is more critical than ever.

More

Webinar

May 12, 2025

Pre-IND and Distribution Strategies: Ensuring Efficient Clinical Studies. Navigating the complexities of early-phase clinical trials requires strategic foresight and regulatory expertise.

More

Webinar

March 27, 2025

Unlocking the Benefits of Customs Warehouse for Pharmaceutical Supply Chains. The global pharmaceutical supply chain is becoming increasingly complex, with regulatory requirements, tax implications, and logistical challenges.

More

Webinar

August 12, 2024

Clinical Trial Directive to Clinical Trial Regulation - Transition. With just over five months left of the legal transition period, it is vital that sponsor companies strategically plan ahead.

More

All videos

Webinar

December 08, 2025

From Clinical to Commercial: Introducing Devices Earlier to Streamline the Drug-Device Combination Journey. Achieving scalability, flexibility, and integration from Phase I to Commercial Launch

More

Webinar

August 19, 2025

Navigating Global Trade Complexities in Pharma: Tariffs, VAT, and Free Trade Zones Explained. understanding how to manage trade compliance and optimize international supply chains is more critical than ever.

More

Webinar

May 12, 2025

Pre-IND and Distribution Strategies: Ensuring Efficient Clinical Studies. Navigating the complexities of early-phase clinical trials requires strategic foresight and regulatory expertise.

More

Webinar

March 27, 2025

Unlocking the Benefits of Customs Warehouse for Pharmaceutical Supply Chains. The global pharmaceutical supply chain is becoming increasingly complex, with regulatory requirements, tax implications, and logistical challenges.

More

Webinar

August 12, 2024

Clinical Trial Directive to Clinical Trial Regulation - Transition. With just over five months left of the legal transition period, it is vital that sponsor companies strategically plan ahead.

More

Webinar

July 30, 2021

Partner Perspectives To De-Risk Commercialization Of Combination Products. Developing an effective drug-device combination product for self-administered biologics is a complex process.

More

All webinars

Whitepaper

October 13, 2023

The Challenge of Pharma Package Design for Manufacturability

More

Whitepaper

October 11, 2023

The Challenges of Scalability in High Potent Manufacturing

More

Whitepaper

June 15, 2023

Digital Transformation: A Critical Component for CDMOs in the Pharmaceutical Industry. Digitization is now a strategic capability for CDMOs in providing pristine customer service to their clients.

More

Whitepaper

July 15, 2022

Optimizing Your Clinical Trial to Commercialization Journey. The average cost of a delayed new drug launch is $15 million per day

More

All whitepapers

Q&A

October 21, 2025

The current pharmaceutical contract manufacturing landscape. Tim Roberts, chief commercial officer for PCI Pharma Services, explores the current pharmaceutical contract manufacturing landscape.

More

Q&A

July 14, 2025

Driving Sterile Innovation at Scale. How the acquisition of Ajinomoto Althea in San Diego, CA significantly augments PCI’s sterile fill-finish offering in North America.

More

Q&A

June 17, 2025

Driving Precision, Agility & Partnership in Complex Drug Development. With the rise of targeted therapies, complex biologics, and ultra-potent small molecules, the role of pharmaceutical development has evolved.

More

Q&A

April 04, 2025

Parenteral Manufacturing and Packaging Trends. How emerging technologies like AI and continuous manufacturing reshaping the landscape of parenteral drug production.

More

All Q&A